ADAR1 Capital Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $583K | Buy |
13,366
+3,366
| +34% | +$147K | 0.09% | 105 |
|
|
2025
Q1 | $274K | Hold |
10,000
| – | – | 0.05% | 126 |
|
|
2024
Q4 | $402K | Sell |
10,000
-1,856
| -16% | -$74.7K | 0.08% | 114 |
|
|
2024
Q3 | $561K | Sell |
11,856
-38,770
| -77% | -$1.83M | 0.09% | 100 |
|
|
2024
Q2 | $1.51M | Buy |
50,626
+34,626
| +216% | +$1.03M | 0.29% | 50 |
|
|
2024
Q1 | $643K | Buy |
+16,000
| New | +$643K | 0.15% | 67 |
|